nodes	percent_of_prediction	percent_of_DWPC	metapath
Valganciclovir—Flatulence—Ezetimibe—atherosclerosis	0.00235	0.00235	CcSEcCtD
Valganciclovir—Pharyngitis—Pravastatin—atherosclerosis	0.00235	0.00235	CcSEcCtD
Valganciclovir—Chills—Simvastatin—atherosclerosis	0.00235	0.00235	CcSEcCtD
Valganciclovir—Muscle spasms—Lovastatin—atherosclerosis	0.00234	0.00234	CcSEcCtD
Valganciclovir—Infection—Rosuvastatin—atherosclerosis	0.00233	0.00233	CcSEcCtD
Valganciclovir—Visual impairment—Niacin—atherosclerosis	0.00231	0.00231	CcSEcCtD
Valganciclovir—Alopecia—Simvastatin—atherosclerosis	0.00231	0.00231	CcSEcCtD
Valganciclovir—Back pain—Ezetimibe—atherosclerosis	0.00231	0.00231	CcSEcCtD
Valganciclovir—Nervous system disorder—Rosuvastatin—atherosclerosis	0.0023	0.0023	CcSEcCtD
Valganciclovir—Muscle spasms—Ezetimibe—atherosclerosis	0.00229	0.00229	CcSEcCtD
Valganciclovir—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00229	0.00229	CcSEcCtD
Valganciclovir—Vision blurred—Lovastatin—atherosclerosis	0.00229	0.00229	CcSEcCtD
Valganciclovir—Mental disorder—Simvastatin—atherosclerosis	0.00229	0.00229	CcSEcCtD
Valganciclovir—Tremor—Lovastatin—atherosclerosis	0.00228	0.00228	CcSEcCtD
Valganciclovir—Visual impairment—Pravastatin—atherosclerosis	0.00228	0.00228	CcSEcCtD
Valganciclovir—Ill-defined disorder—Lovastatin—atherosclerosis	0.00226	0.00226	CcSEcCtD
Valganciclovir—Eye disorder—Niacin—atherosclerosis	0.00224	0.00224	CcSEcCtD
Valganciclovir—Flatulence—Simvastatin—atherosclerosis	0.00224	0.00224	CcSEcCtD
Valganciclovir—Tinnitus—Niacin—atherosclerosis	0.00224	0.00224	CcSEcCtD
Valganciclovir—Dysgeusia—Simvastatin—atherosclerosis	0.00223	0.00223	CcSEcCtD
Valganciclovir—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00221	0.00221	CcSEcCtD
Valganciclovir—Anaemia—Ezetimibe—atherosclerosis	0.00221	0.00221	CcSEcCtD
Valganciclovir—Tinnitus—Pravastatin—atherosclerosis	0.0022	0.0022	CcSEcCtD
Valganciclovir—Malaise—Lovastatin—atherosclerosis	0.00219	0.00219	CcSEcCtD
Valganciclovir—Cardiac disorder—Pravastatin—atherosclerosis	0.00219	0.00219	CcSEcCtD
Valganciclovir—Muscle spasms—Simvastatin—atherosclerosis	0.00219	0.00219	CcSEcCtD
Valganciclovir—Vertigo—Lovastatin—atherosclerosis	0.00219	0.00219	CcSEcCtD
Valganciclovir—Angiopathy—Niacin—atherosclerosis	0.00218	0.00218	CcSEcCtD
Valganciclovir—Leukopenia—Lovastatin—atherosclerosis	0.00218	0.00218	CcSEcCtD
Valganciclovir—Chills—Niacin—atherosclerosis	0.00215	0.00215	CcSEcCtD
Valganciclovir—Malaise—Ezetimibe—atherosclerosis	0.00215	0.00215	CcSEcCtD
Valganciclovir—Vision blurred—Simvastatin—atherosclerosis	0.00214	0.00214	CcSEcCtD
Valganciclovir—Arrhythmia—Niacin—atherosclerosis	0.00214	0.00214	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00213	0.00213	CcSEcCtD
Valganciclovir—Tremor—Simvastatin—atherosclerosis	0.00213	0.00213	CcSEcCtD
Valganciclovir—Alopecia—Niacin—atherosclerosis	0.00212	0.00212	CcSEcCtD
Valganciclovir—Chills—Pravastatin—atherosclerosis	0.00212	0.00212	CcSEcCtD
Valganciclovir—Insomnia—Rosuvastatin—atherosclerosis	0.00212	0.00212	CcSEcCtD
Valganciclovir—Ill-defined disorder—Simvastatin—atherosclerosis	0.00211	0.00211	CcSEcCtD
Valganciclovir—Arrhythmia—Pravastatin—atherosclerosis	0.00211	0.00211	CcSEcCtD
Valganciclovir—Paraesthesia—Rosuvastatin—atherosclerosis	0.0021	0.0021	CcSEcCtD
Valganciclovir—Anaemia—Simvastatin—atherosclerosis	0.0021	0.0021	CcSEcCtD
Valganciclovir—Malnutrition—Niacin—atherosclerosis	0.00209	0.00209	CcSEcCtD
Valganciclovir—Alopecia—Pravastatin—atherosclerosis	0.00209	0.00209	CcSEcCtD
Valganciclovir—Cough—Ezetimibe—atherosclerosis	0.00208	0.00208	CcSEcCtD
Valganciclovir—Arthralgia—Lovastatin—atherosclerosis	0.00207	0.00207	CcSEcCtD
Valganciclovir—Anxiety—Lovastatin—atherosclerosis	0.00206	0.00206	CcSEcCtD
Valganciclovir—Dyspepsia—Rosuvastatin—atherosclerosis	0.00206	0.00206	CcSEcCtD
Valganciclovir—Hypertension—Ezetimibe—atherosclerosis	0.00206	0.00206	CcSEcCtD
Valganciclovir—Flatulence—Niacin—atherosclerosis	0.00206	0.00206	CcSEcCtD
Valganciclovir—Malaise—Simvastatin—atherosclerosis	0.00205	0.00205	CcSEcCtD
Valganciclovir—Tension—Niacin—atherosclerosis	0.00205	0.00205	CcSEcCtD
Valganciclovir—Discomfort—Lovastatin—atherosclerosis	0.00205	0.00205	CcSEcCtD
Valganciclovir—Vertigo—Simvastatin—atherosclerosis	0.00204	0.00204	CcSEcCtD
Valganciclovir—Leukopenia—Simvastatin—atherosclerosis	0.00204	0.00204	CcSEcCtD
Valganciclovir—Arthralgia—Ezetimibe—atherosclerosis	0.00203	0.00203	CcSEcCtD
Valganciclovir—Nervousness—Niacin—atherosclerosis	0.00203	0.00203	CcSEcCtD
Valganciclovir—Flatulence—Pravastatin—atherosclerosis	0.00203	0.00203	CcSEcCtD
Valganciclovir—Dry mouth—Lovastatin—atherosclerosis	0.00203	0.00203	CcSEcCtD
Valganciclovir—Tension—Pravastatin—atherosclerosis	0.00202	0.00202	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00202	0.00202	CcSEcCtD
Valganciclovir—Dysgeusia—Pravastatin—atherosclerosis	0.00202	0.00202	CcSEcCtD
Valganciclovir—Muscle spasms—Niacin—atherosclerosis	0.00201	0.00201	CcSEcCtD
Valganciclovir—Discomfort—Ezetimibe—atherosclerosis	0.00201	0.00201	CcSEcCtD
Valganciclovir—Pain—Rosuvastatin—atherosclerosis	0.002	0.002	CcSEcCtD
Valganciclovir—Constipation—Rosuvastatin—atherosclerosis	0.002	0.002	CcSEcCtD
Valganciclovir—Confusional state—Lovastatin—atherosclerosis	0.002	0.002	CcSEcCtD
Valganciclovir—Nervousness—Pravastatin—atherosclerosis	0.002	0.002	CcSEcCtD
Valganciclovir—Dry mouth—Ezetimibe—atherosclerosis	0.00199	0.00199	CcSEcCtD
Valganciclovir—Anaphylactic shock—Lovastatin—atherosclerosis	0.00199	0.00199	CcSEcCtD
Valganciclovir—Muscle spasms—Pravastatin—atherosclerosis	0.00198	0.00198	CcSEcCtD
Valganciclovir—Infection—Lovastatin—atherosclerosis	0.00197	0.00197	CcSEcCtD
Valganciclovir—Vision blurred—Niacin—atherosclerosis	0.00197	0.00197	CcSEcCtD
Valganciclovir—Confusional state—Ezetimibe—atherosclerosis	0.00196	0.00196	CcSEcCtD
Valganciclovir—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00195	0.00195	CcSEcCtD
Valganciclovir—Thrombocytopenia—Lovastatin—atherosclerosis	0.00194	0.00194	CcSEcCtD
Valganciclovir—Vision blurred—Pravastatin—atherosclerosis	0.00194	0.00194	CcSEcCtD
Valganciclovir—Arthralgia—Simvastatin—atherosclerosis	0.00194	0.00194	CcSEcCtD
Valganciclovir—Infection—Ezetimibe—atherosclerosis	0.00194	0.00194	CcSEcCtD
Valganciclovir—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00193	0.00193	CcSEcCtD
Valganciclovir—Anxiety—Simvastatin—atherosclerosis	0.00193	0.00193	CcSEcCtD
Valganciclovir—Tremor—Pravastatin—atherosclerosis	0.00193	0.00193	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00192	0.00192	CcSEcCtD
Valganciclovir—Discomfort—Simvastatin—atherosclerosis	0.00191	0.00191	CcSEcCtD
Valganciclovir—Nervous system disorder—Ezetimibe—atherosclerosis	0.00191	0.00191	CcSEcCtD
Valganciclovir—Ill-defined disorder—Pravastatin—atherosclerosis	0.00191	0.00191	CcSEcCtD
Valganciclovir—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00191	0.00191	CcSEcCtD
Valganciclovir—Anaemia—Pravastatin—atherosclerosis	0.0019	0.0019	CcSEcCtD
Valganciclovir—Anorexia—Lovastatin—atherosclerosis	0.00189	0.00189	CcSEcCtD
Valganciclovir—Skin disorder—Ezetimibe—atherosclerosis	0.00189	0.00189	CcSEcCtD
Valganciclovir—Vertigo—Niacin—atherosclerosis	0.00188	0.00188	CcSEcCtD
Valganciclovir—Confusional state—Simvastatin—atherosclerosis	0.00187	0.00187	CcSEcCtD
Valganciclovir—Leukopenia—Niacin—atherosclerosis	0.00187	0.00187	CcSEcCtD
Valganciclovir—Urticaria—Rosuvastatin—atherosclerosis	0.00186	0.00186	CcSEcCtD
Valganciclovir—Anaphylactic shock—Simvastatin—atherosclerosis	0.00186	0.00186	CcSEcCtD
Valganciclovir—Oedema—Simvastatin—atherosclerosis	0.00186	0.00186	CcSEcCtD
Valganciclovir—Malaise—Pravastatin—atherosclerosis	0.00186	0.00186	CcSEcCtD
Valganciclovir—Abdominal pain—Rosuvastatin—atherosclerosis	0.00185	0.00185	CcSEcCtD
Valganciclovir—Vertigo—Pravastatin—atherosclerosis	0.00185	0.00185	CcSEcCtD
Valganciclovir—Infection—Simvastatin—atherosclerosis	0.00185	0.00185	CcSEcCtD
Valganciclovir—Leukopenia—Pravastatin—atherosclerosis	0.00184	0.00184	CcSEcCtD
Valganciclovir—Cough—Niacin—atherosclerosis	0.00182	0.00182	CcSEcCtD
Valganciclovir—Thrombocytopenia—Simvastatin—atherosclerosis	0.00182	0.00182	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00181	0.00181	CcSEcCtD
Valganciclovir—Insomnia—Lovastatin—atherosclerosis	0.0018	0.0018	CcSEcCtD
Valganciclovir—Cough—Pravastatin—atherosclerosis	0.0018	0.0018	CcSEcCtD
Valganciclovir—Paraesthesia—Lovastatin—atherosclerosis	0.00178	0.00178	CcSEcCtD
Valganciclovir—Arthralgia—Niacin—atherosclerosis	0.00178	0.00178	CcSEcCtD
Valganciclovir—Hypertension—Pravastatin—atherosclerosis	0.00178	0.00178	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00177	0.00177	CcSEcCtD
Valganciclovir—Anorexia—Simvastatin—atherosclerosis	0.00177	0.00177	CcSEcCtD
Valganciclovir—Dyspnoea—Lovastatin—atherosclerosis	0.00177	0.00177	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00177	0.00177	CcSEcCtD
Valganciclovir—Insomnia—Ezetimibe—atherosclerosis	0.00176	0.00176	CcSEcCtD
Valganciclovir—Arthralgia—Pravastatin—atherosclerosis	0.00175	0.00175	CcSEcCtD
Valganciclovir—Paraesthesia—Ezetimibe—atherosclerosis	0.00175	0.00175	CcSEcCtD
Valganciclovir—Dyspepsia—Lovastatin—atherosclerosis	0.00175	0.00175	CcSEcCtD
Valganciclovir—Anxiety—Pravastatin—atherosclerosis	0.00175	0.00175	CcSEcCtD
Valganciclovir—Dry mouth—Niacin—atherosclerosis	0.00174	0.00174	CcSEcCtD
Valganciclovir—Dyspnoea—Ezetimibe—atherosclerosis	0.00174	0.00174	CcSEcCtD
Valganciclovir—Discomfort—Pravastatin—atherosclerosis	0.00173	0.00173	CcSEcCtD
Valganciclovir—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00173	0.00173	CcSEcCtD
Valganciclovir—Decreased appetite—Lovastatin—atherosclerosis	0.00173	0.00173	CcSEcCtD
Valganciclovir—Dyspepsia—Ezetimibe—atherosclerosis	0.00171	0.00171	CcSEcCtD
Valganciclovir—Fatigue—Lovastatin—atherosclerosis	0.00171	0.00171	CcSEcCtD
Valganciclovir—Anaphylactic shock—Niacin—atherosclerosis	0.00171	0.00171	CcSEcCtD
Valganciclovir—Oedema—Niacin—atherosclerosis	0.00171	0.00171	CcSEcCtD
Valganciclovir—Pain—Lovastatin—atherosclerosis	0.0017	0.0017	CcSEcCtD
Valganciclovir—Constipation—Lovastatin—atherosclerosis	0.0017	0.0017	CcSEcCtD
Valganciclovir—Confusional state—Pravastatin—atherosclerosis	0.00169	0.00169	CcSEcCtD
Valganciclovir—Decreased appetite—Ezetimibe—atherosclerosis	0.00169	0.00169	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00169	0.00169	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00168	0.00168	CcSEcCtD
Valganciclovir—Asthenia—Rosuvastatin—atherosclerosis	0.00168	0.00168	CcSEcCtD
Valganciclovir—Insomnia—Simvastatin—atherosclerosis	0.00168	0.00168	CcSEcCtD
Valganciclovir—Anaphylactic shock—Pravastatin—atherosclerosis	0.00168	0.00168	CcSEcCtD
Valganciclovir—Oedema—Pravastatin—atherosclerosis	0.00168	0.00168	CcSEcCtD
Valganciclovir—Fatigue—Ezetimibe—atherosclerosis	0.00168	0.00168	CcSEcCtD
Valganciclovir—Infection—Pravastatin—atherosclerosis	0.00167	0.00167	CcSEcCtD
Valganciclovir—Paraesthesia—Simvastatin—atherosclerosis	0.00167	0.00167	CcSEcCtD
Valganciclovir—Pain—Ezetimibe—atherosclerosis	0.00167	0.00167	CcSEcCtD
Valganciclovir—Constipation—Ezetimibe—atherosclerosis	0.00167	0.00167	CcSEcCtD
Valganciclovir—Tachycardia—Niacin—atherosclerosis	0.00166	0.00166	CcSEcCtD
Valganciclovir—Pruritus—Rosuvastatin—atherosclerosis	0.00166	0.00166	CcSEcCtD
Valganciclovir—Skin disorder—Niacin—atherosclerosis	0.00166	0.00166	CcSEcCtD
Valganciclovir—Dyspnoea—Simvastatin—atherosclerosis	0.00166	0.00166	CcSEcCtD
Valganciclovir—Hyperhidrosis—Niacin—atherosclerosis	0.00165	0.00165	CcSEcCtD
Valganciclovir—Thrombocytopenia—Pravastatin—atherosclerosis	0.00164	0.00164	CcSEcCtD
Valganciclovir—Feeling abnormal—Lovastatin—atherosclerosis	0.00164	0.00164	CcSEcCtD
Valganciclovir—Dyspepsia—Simvastatin—atherosclerosis	0.00164	0.00164	CcSEcCtD
Valganciclovir—Anorexia—Niacin—atherosclerosis	0.00163	0.00163	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00162	0.00162	CcSEcCtD
Valganciclovir—Hyperhidrosis—Pravastatin—atherosclerosis	0.00162	0.00162	CcSEcCtD
Valganciclovir—Decreased appetite—Simvastatin—atherosclerosis	0.00161	0.00161	CcSEcCtD
Valganciclovir—Feeling abnormal—Ezetimibe—atherosclerosis	0.00161	0.00161	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.0016	0.0016	CcSEcCtD
Valganciclovir—Diarrhoea—Rosuvastatin—atherosclerosis	0.0016	0.0016	CcSEcCtD
Valganciclovir—Fatigue—Simvastatin—atherosclerosis	0.0016	0.0016	CcSEcCtD
Valganciclovir—Anorexia—Pravastatin—atherosclerosis	0.0016	0.0016	CcSEcCtD
Valganciclovir—Hypotension—Niacin—atherosclerosis	0.00159	0.00159	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00159	0.00159	CcSEcCtD
Valganciclovir—Pain—Simvastatin—atherosclerosis	0.00159	0.00159	CcSEcCtD
Valganciclovir—Constipation—Simvastatin—atherosclerosis	0.00159	0.00159	CcSEcCtD
Valganciclovir—Urticaria—Lovastatin—atherosclerosis	0.00158	0.00158	CcSEcCtD
Valganciclovir—Abdominal pain—Lovastatin—atherosclerosis	0.00157	0.00157	CcSEcCtD
Valganciclovir—Body temperature increased—Lovastatin—atherosclerosis	0.00157	0.00157	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00155	0.00155	CcSEcCtD
Valganciclovir—Dizziness—Rosuvastatin—atherosclerosis	0.00155	0.00155	CcSEcCtD
Valganciclovir—Urticaria—Ezetimibe—atherosclerosis	0.00155	0.00155	CcSEcCtD
Valganciclovir—Insomnia—Niacin—atherosclerosis	0.00154	0.00154	CcSEcCtD
Valganciclovir—Abdominal pain—Ezetimibe—atherosclerosis	0.00154	0.00154	CcSEcCtD
Valganciclovir—Body temperature increased—Ezetimibe—atherosclerosis	0.00154	0.00154	CcSEcCtD
Valganciclovir—Paraesthesia—Niacin—atherosclerosis	0.00153	0.00153	CcSEcCtD
Valganciclovir—Feeling abnormal—Simvastatin—atherosclerosis	0.00153	0.00153	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00153	0.00153	CcSEcCtD
Valganciclovir—Dyspnoea—Niacin—atherosclerosis	0.00152	0.00152	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00152	0.00152	CcSEcCtD
Valganciclovir—Insomnia—Pravastatin—atherosclerosis	0.00152	0.00152	CcSEcCtD
Valganciclovir—Somnolence—Niacin—atherosclerosis	0.00152	0.00152	CcSEcCtD
Valganciclovir—Paraesthesia—Pravastatin—atherosclerosis	0.00151	0.00151	CcSEcCtD
Valganciclovir—Dyspepsia—Niacin—atherosclerosis	0.0015	0.0015	CcSEcCtD
Valganciclovir—Dyspnoea—Pravastatin—atherosclerosis	0.0015	0.0015	CcSEcCtD
Valganciclovir—Decreased appetite—Niacin—atherosclerosis	0.00148	0.00148	CcSEcCtD
Valganciclovir—Dyspepsia—Pravastatin—atherosclerosis	0.00148	0.00148	CcSEcCtD
Valganciclovir—Dermatitis—Rosuvastatin—atherosclerosis	0.00148	0.00148	CcSEcCtD
Valganciclovir—Urticaria—Simvastatin—atherosclerosis	0.00148	0.00148	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Niacin—atherosclerosis	0.00147	0.00147	CcSEcCtD
Valganciclovir—Body temperature increased—Simvastatin—atherosclerosis	0.00147	0.00147	CcSEcCtD
Valganciclovir—Abdominal pain—Simvastatin—atherosclerosis	0.00147	0.00147	CcSEcCtD
Valganciclovir—Headache—Rosuvastatin—atherosclerosis	0.00147	0.00147	CcSEcCtD
Valganciclovir—Hypersensitivity—Lovastatin—atherosclerosis	0.00146	0.00146	CcSEcCtD
Valganciclovir—Decreased appetite—Pravastatin—atherosclerosis	0.00146	0.00146	CcSEcCtD
Valganciclovir—Pain—Niacin—atherosclerosis	0.00146	0.00146	CcSEcCtD
Valganciclovir—Fatigue—Pravastatin—atherosclerosis	0.00145	0.00145	CcSEcCtD
Valganciclovir—Pain—Pravastatin—atherosclerosis	0.00144	0.00144	CcSEcCtD
Valganciclovir—Constipation—Pravastatin—atherosclerosis	0.00144	0.00144	CcSEcCtD
Valganciclovir—Hypersensitivity—Ezetimibe—atherosclerosis	0.00144	0.00144	CcSEcCtD
Valganciclovir—Asthenia—Lovastatin—atherosclerosis	0.00142	0.00142	CcSEcCtD
Valganciclovir—Pruritus—Lovastatin—atherosclerosis	0.00141	0.00141	CcSEcCtD
Valganciclovir—Asthenia—Ezetimibe—atherosclerosis	0.0014	0.0014	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Niacin—atherosclerosis	0.00139	0.00139	CcSEcCtD
Valganciclovir—Nausea—Rosuvastatin—atherosclerosis	0.00139	0.00139	CcSEcCtD
Valganciclovir—Feeling abnormal—Pravastatin—atherosclerosis	0.00138	0.00138	CcSEcCtD
Valganciclovir—Pruritus—Ezetimibe—atherosclerosis	0.00138	0.00138	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00137	0.00137	CcSEcCtD
Valganciclovir—Hypersensitivity—Simvastatin—atherosclerosis	0.00137	0.00137	CcSEcCtD
Valganciclovir—Diarrhoea—Lovastatin—atherosclerosis	0.00136	0.00136	CcSEcCtD
Valganciclovir—Urticaria—Niacin—atherosclerosis	0.00135	0.00135	CcSEcCtD
Valganciclovir—Body temperature increased—Niacin—atherosclerosis	0.00135	0.00135	CcSEcCtD
Valganciclovir—Abdominal pain—Niacin—atherosclerosis	0.00135	0.00135	CcSEcCtD
Valganciclovir—Urticaria—Pravastatin—atherosclerosis	0.00133	0.00133	CcSEcCtD
Valganciclovir—Asthenia—Simvastatin—atherosclerosis	0.00133	0.00133	CcSEcCtD
Valganciclovir—Diarrhoea—Ezetimibe—atherosclerosis	0.00133	0.00133	CcSEcCtD
Valganciclovir—Abdominal pain—Pravastatin—atherosclerosis	0.00133	0.00133	CcSEcCtD
Valganciclovir—Body temperature increased—Pravastatin—atherosclerosis	0.00133	0.00133	CcSEcCtD
Valganciclovir—Pruritus—Simvastatin—atherosclerosis	0.00131	0.00131	CcSEcCtD
Valganciclovir—Dizziness—Lovastatin—atherosclerosis	0.00131	0.00131	CcSEcCtD
Valganciclovir—Dizziness—Ezetimibe—atherosclerosis	0.00129	0.00129	CcSEcCtD
Valganciclovir—Diarrhoea—Simvastatin—atherosclerosis	0.00127	0.00127	CcSEcCtD
Valganciclovir—Vomiting—Lovastatin—atherosclerosis	0.00126	0.00126	CcSEcCtD
Valganciclovir—Hypersensitivity—Niacin—atherosclerosis	0.00126	0.00126	CcSEcCtD
Valganciclovir—Dermatitis—Lovastatin—atherosclerosis	0.00125	0.00125	CcSEcCtD
Valganciclovir—Headache—Lovastatin—atherosclerosis	0.00124	0.00124	CcSEcCtD
Valganciclovir—Vomiting—Ezetimibe—atherosclerosis	0.00124	0.00124	CcSEcCtD
Valganciclovir—Hypersensitivity—Pravastatin—atherosclerosis	0.00124	0.00124	CcSEcCtD
Valganciclovir—Dizziness—Simvastatin—atherosclerosis	0.00123	0.00123	CcSEcCtD
Valganciclovir—Dermatitis—Ezetimibe—atherosclerosis	0.00123	0.00123	CcSEcCtD
Valganciclovir—Asthenia—Niacin—atherosclerosis	0.00122	0.00122	CcSEcCtD
Valganciclovir—Headache—Ezetimibe—atherosclerosis	0.00122	0.00122	CcSEcCtD
Valganciclovir—Pruritus—Niacin—atherosclerosis	0.00121	0.00121	CcSEcCtD
Valganciclovir—Asthenia—Pravastatin—atherosclerosis	0.0012	0.0012	CcSEcCtD
Valganciclovir—Pruritus—Pravastatin—atherosclerosis	0.00119	0.00119	CcSEcCtD
Valganciclovir—Vomiting—Simvastatin—atherosclerosis	0.00118	0.00118	CcSEcCtD
Valganciclovir—Nausea—Lovastatin—atherosclerosis	0.00118	0.00118	CcSEcCtD
Valganciclovir—Dermatitis—Simvastatin—atherosclerosis	0.00117	0.00117	CcSEcCtD
Valganciclovir—Diarrhoea—Niacin—atherosclerosis	0.00117	0.00117	CcSEcCtD
Valganciclovir—Headache—Simvastatin—atherosclerosis	0.00116	0.00116	CcSEcCtD
Valganciclovir—Nausea—Ezetimibe—atherosclerosis	0.00116	0.00116	CcSEcCtD
Valganciclovir—Diarrhoea—Pravastatin—atherosclerosis	0.00115	0.00115	CcSEcCtD
Valganciclovir—Dizziness—Niacin—atherosclerosis	0.00113	0.00113	CcSEcCtD
Valganciclovir—Dizziness—Pravastatin—atherosclerosis	0.00111	0.00111	CcSEcCtD
Valganciclovir—Nausea—Simvastatin—atherosclerosis	0.0011	0.0011	CcSEcCtD
Valganciclovir—Vomiting—Niacin—atherosclerosis	0.00108	0.00108	CcSEcCtD
Valganciclovir—Dermatitis—Niacin—atherosclerosis	0.00107	0.00107	CcSEcCtD
Valganciclovir—Headache—Niacin—atherosclerosis	0.00107	0.00107	CcSEcCtD
Valganciclovir—Vomiting—Pravastatin—atherosclerosis	0.00107	0.00107	CcSEcCtD
Valganciclovir—Dermatitis—Pravastatin—atherosclerosis	0.00106	0.00106	CcSEcCtD
Valganciclovir—Headache—Pravastatin—atherosclerosis	0.00105	0.00105	CcSEcCtD
Valganciclovir—Nausea—Niacin—atherosclerosis	0.00101	0.00101	CcSEcCtD
Valganciclovir—Nausea—Pravastatin—atherosclerosis	0.000998	0.000998	CcSEcCtD
